← Leaderboards
Chunyan Zhang
Beckman Research Institute/City Of Hope
$910,223
Attributed
$910,223
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $452.5K · FY2020–25$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$910,223 · 2
By mechanism
R21$910,223 · 2
Top collaborators
No co-investigators on record.
Most similar at Beckman Research Institute/City Of Hope
Same institution · by research overlap
- Ibrahim Aldoss$1,000,623
- Xiuli Wang$2,702,470
- Mingye Feng$6,090,660
- Javier Gordon Ogembo$11,510,265
- Srividya Swaminathan$1,708,226
Others in their field
Other Emerging Leaders on “Interferon Type Ii”
- Thomas Denny · Duke University$19,381,749
- Seungmin Hwang · University Of Chicago$4,817,359
- Michael Daniel Keller · Children'S Research Institute$4,223,988
- Michael Levin · Imperial College Of Science, Technology And Medicine$3,954,510
- Natura Myeku · Columbia University Health Sciences$3,828,607
- William Karl Decker · Baylor College Of Medicine$3,693,786
Research focus
Interferon Type IiMetabolicImmuneInsightMalignant Breast NeoplasmMalignant NeoplasmsExhaustionGlycolysisAnti-Tumor Immune ResponseInfiltrationInterleukin-10Interleukin 6 ReceptorB-LymphocytesBreast Cancer ModelBreast Cancer PatientAntibodiesFatty Acid OxidationCarnitine Palmitoyltransferase ICd8b1 GeneCd8-Positive T-LymphocytesCellsImmunotherapyCheckpoint InhibitionMetabolism
Grant awards (3)
Developing a novel therapeutic strategy for overcoming resistance to PD-1 blockade in Triple-negative breast cancer$249,645
R21 · FY2025 · CA · contact PI
Developing a novel therapeutic strategy for overcoming resistance to PD-1 blockade in Triple-negative breast cancer$208,038
R21 · FY2024 · CA · contact PI
Targeting CD5 on Tumor-associated T and B cells to improve PD-1 blockade in Breast Cancer$452,540
R21 · FY2020 · CA · contact PI